Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "Eva L. Feldman" Clear advanced filters
  • Amyotrophic lateral sclerosis (ALS) involves a complex interaction between genetic susceptibility and environmental insults. In this Review, Paez-Colasante and colleagues discuss various disease mechanisms that might apply to ALS, with particular emphasis on epigenetic factors. To date, only one treatment even modestly improves survival in patients with ALS, and the authors discuss several potential new therapeutic targets.

    • Ximena Paez-Colasante
    • Claudia Figueroa-Romero
    • Eva L. Feldman
    Reviews
    Nature Reviews Neurology
    Volume: 11, P: 266-279
  • John W. 'Jack' Griffin (1942–2011) was the launch Editor-in-Chief ofNature Clinical Practice Neurology, and continued to serve on the Advisory Board after the journal was rebranded as Nature Reviews Neurologyin 2009. In this Essay, the authors pay tribute to Jack, highlighting his seminal contributions to the field of inflammatory neuropathies, and reviewing recent progress in this area, including the emergence of the node of Ranvier as a site of intensive investigation.

    • Eva L. Feldman
    • Richard A. C. Hughes
    • Hugh J. Willison
    Comments & Opinion
    Nature Reviews Neurology
    Volume: 11, P: 646-650
  • The pathophysiological processes underlying onset and progression of amyotrophic lateral sclerosis (ALS) remain poorly understood. Unlike conventional imaging techniques, which provide information only at a gross structural level, advanced imaging modalities have shed light on the microstructural changes that accompany this disease. Eva Feldman and colleagues describe how advanced neuroimaging studies have delineated key factors, such as white matter tract integrity and brain metabolism, that are altered in ALS, and consider how such insights could aid diagnosis and treatment.

    • Bradley R. Foerster
    • Robert C. Welsh
    • Eva L. Feldman
    Reviews
    Nature Reviews Neurology
    Volume: 9, P: 513-524
  • Diabetic neuropathy is the most common complication of diabetes mellitus, and there are currently no effective treatments for this condition. In this Review, Leinninger et al. discuss the proposed role of mitochondrial degeneration in the pathogenesis of diabetic neuropathy, and highlight potential mitochondrial sites for therapeutic intervention.

    • Gina M Leinninger
    • James L Edwards
    • Eva L Feldman
    Reviews
    Nature Clinical Practice Neurology
    Volume: 2, P: 620-628
  • Neuropathy is the most common complication of diabetes and considerably reduces patient quality of life, yet no disease-modifying therapies are currently available and symptomatic treatments generally provide only partial relief. Vincent and colleagues provide an update on the cellular mechanisms that lead to diabetic neuropathy, which involves a complex interplay between oxidative and inflammatory pathways in neurons, Schwann cells and the microvascular endothelium. The authors highlight potential new therapeutic targets and discuss drug candidates that are in development for this debilitating diabetic complication.

    • Andrea M. Vincent
    • Brian C. Callaghan
    • Eva L. Feldman
    Reviews
    Nature Reviews Neurology
    Volume: 7, P: 573-583